Medicare Enrolled

Dr. Mahesh Mansukhani, M.D.

Molecular Genetic Pathology (Pathology) Physician · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
622 W 168TH ST, New York, NY 10032
2123052646
In practice since 2007 (19 years)
NPI: 1477692556 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mansukhani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mansukhani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mansukhani

Dr. Mahesh Mansukhani is a molecular genetic pathology physician in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mansukhani performed 912 Medicare services across 496 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mansukhani received a total of $811 from 2 pharmaceutical and/or device companies across 4 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in molecular genetic pathology (pathology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mansukhani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 912 Medicare services $811 industry payments

Medicare Practice Summary

Medicare Utilization ↗
912
Medicare services
Bottom 31% in NY for molecular genetic pathology (pathology) physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
496
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~48 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Chromosome analysis for genetic defects, 100-300 cells
A laboratory test that examines 100 to 300 cells to analyze chromosomes for genetic defects.
 353 $50 $220
DNA testing for genetic defects
A laboratory test that analyzes DNA to identify specific genetic abnormalities or mutations. This procedure is used to detect inherited conditions or predispositions associated with genetic defects.
 168 $21 $100
Tissue culture for bone marrow and blood cell tumor disorders
A laboratory test that grows bone marrow or blood cells in a culture to analyze tumor disorders.
 134 $141 $540
Additional chromosome analysis study
This procedure involves performing an additional karyotype analysis to examine chromosomes for genetic defects. It is billed as a separate study beyond the initial analysis.
 115 $33 $140
Chromosome analysis for genetic defects
A laboratory test that examines 15 to 20 cells to check for genetic defects in the chromosomes.
 110 $123 $660
Manual urine cell examination
A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells.
 19 $501 $2,250
Chromosome analysis, 5 cells
A genetic test that examines the structure and number of chromosomes in five cells to identify defects.
 13 $259 $940
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2018 ↗
$811
Total received (2018-2018)
Top 46% in NY for molecular genetic pathology (pathology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
2
Companies
4
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$811 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2018
$811

Payments by company (2018)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$795
VENTANA MEDICAL SYSTEMS, INC.
$16
Top 3 companies account for 100.0% of 2018 payments
Associated products mentioned in payments ›
BENCHMARK IHC/ISH PLATFORMS & REAGENTS · OPDIVO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a molecular genetic pathology physician in New York?
Compare molecular genetic pathology physicians in the New York area by procedure volume, costs, and industry payment transparency.
Browse molecular genetic pathology physicians nearby

Geographic Context

Molecular genetic pathology physicians within 10 mi
20
Per 100K population
1.2
County median income
$104,553
Nearest hospital
NEW YORK STATE PSYCHIATRIC INSTITUTE
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2018
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mansukhani is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mansukhani experienced with chromosome analysis for genetic defects, 100-300 cells?
Based on Medicare claims data, Dr. Mansukhani performed 353 chromosome analysis for genetic defects, 100-300 cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mansukhani receive payments from pharmaceutical companies?
Yes. Dr. Mansukhani received a total of $811 from 2 companies across 4 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mansukhani's costs compare to other molecular genetic pathology physicians in New York?
Dr. Mansukhani's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mansukhani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Molecular Genetic Pathology Physicians in New York
Browse molecular genetic pathology physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Molecular Genetic Pathology Physicians in NY
Molecular genetic pathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Molecular Genetic Pathology Physicians in NY
Which NY molecular genetic pathology physicians receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
VENTANA MEDICAL SYSTEMS, INC. Payments to Doctors
See all physicians who received payments from VENTANA MEDICAL SYSTEMS, INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →